 2. Had clinical evidence of significant, unstable or uncontrolled, acute or chronic diseases not due to RA ie, cardiovascular, pulmonary, anemia, gastrointestinal, hepatic, renal, neurological, cancer or infectious diseases that could, in the opinion of the principal investigator, put the patient at undue risk. 